Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mervyn Singer

Showing results (11-20 of 463) with videos related to

Pageof 47
Sort By:
Critical Care (London, England)|June 16, 2019
Sepsis: personalization v protocolization?Mervyn Singer
Critical Care (London, England)|September 4, 2007
Why aren't we practising homogenized medicine?Mervyn Singer
Critical Care (London, England)|March 18, 2006
The key advance in the treatment of sepsis in the last 10 years...doing lessMervyn Singer
Critical Care Medicine|June 10, 2003
ODM/CardioQ esophageal Doppler technologyMervyn Singer
The Medical Journal of Australia|December 9, 2020
Outcomes for patients with COVID-19: known knowns, known unknowns, and unknown unknownsMervyn Singer
Novartis Foundation Symposium|March 27, 2007
System interactionsMervyn Singer
Critical Care Medicine|September 22, 2007
Mitochondrial function in sepsis: acute phase versus multiple organ failureMervyn Singer
Current Opinion in Anaesthesiology|December 14, 2011
Management of fluid balance: a European perspectiveMervyn Singer
Critical Care Medicine|December 13, 2005
Metabolic failureMervyn Singer
Lancet (London, England)|August 28, 2007
Catecholamine treatment for shock--equally good or bad?Mervyn Singer
Pageof 47

Showing results (11-20 of 463) with videos related to

Sort By:
Pageof 47
Critical Care (London, England)|June 16, 2019
Sepsis: personalization v protocolization?Mervyn Singer
Critical Care (London, England)|September 4, 2007
Why aren't we practising homogenized medicine?Mervyn Singer
Critical Care (London, England)|March 18, 2006
The key advance in the treatment of sepsis in the last 10 years...doing lessMervyn Singer
Critical Care Medicine|June 10, 2003
ODM/CardioQ esophageal Doppler technologyMervyn Singer
The Medical Journal of Australia|December 9, 2020
Outcomes for patients with COVID-19: known knowns, known unknowns, and unknown unknownsMervyn Singer
Novartis Foundation Symposium|March 27, 2007
System interactionsMervyn Singer
Critical Care Medicine|September 22, 2007
Mitochondrial function in sepsis: acute phase versus multiple organ failureMervyn Singer
Current Opinion in Anaesthesiology|December 14, 2011
Management of fluid balance: a European perspectiveMervyn Singer
Critical Care Medicine|December 13, 2005
Metabolic failureMervyn Singer
Lancet (London, England)|August 28, 2007
Catecholamine treatment for shock--equally good or bad?Mervyn Singer
Pageof 47